Metformin cream versus triple cream for skin darkening
Part of Skin clinical trials.
This study compares a cream containing metformin to a triple combination cream for treating melasma, which causes brown patches on the face. The goal is to see which treatment is more effective in lightening these patches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- Your skin darkening is the epidermal type (confirmed by a Wood's lamp test).
- You have not used any melasma treatment in the past month.
- You have not had procedures like dermabrasion, laser, or chemical peels in the past 3 months.
- You are not pregnant and do not have other skin conditions like acne or rosacea.
- You can provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new cosmetic serum to a standard treatment (4% hydroquinone) for facial melasma over 84 days. It may help if you have mild to moderate melasma and are looking for a gentler alternative.
This study compares a metformin cream to a standard treatment (Kligman's regimen) for reducing melasma, a common skin condition causing dark patches on the face. It aims to find which treatment is more effective for women with this condition.
This study compares two creams — metformin and tranexamic acid — to see which works better for melasma (dark patches on the face). If you qualify, you'll use one of the creams and your progress will be checked over time.
This study compares two different combination creams for treating melasma, a common skin condition causing dark patches on the face. One cream includes a mild steroid and the other has a different steroid, both with the same lightening ingredients. The goal is to see which works better and is safer for your skin.
This study compares two different creams applied to the skin — metformin and ketotifen — to see which works better for treating melasma (dark patches on the face). If you are a woman with melasma, you may be eligible to join and receive one of these creams.
This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.
Hear when a new Epidermal Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.